|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2008-08-21|
|Study Made Public:||2012-06-15|
Weiss mAbs potency
CAVD 235 is a monoclonal antibody study to characterize mAbs isolated and produced from IgG+ memory B cells of non-clade B HIV-1 infected donors, using a representative panel of HIV-1 primary isolates.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.